Senior Training Manager, Manufacturing - (Smithfield, RI)

Rubius Therapeutics is a biopharmaceutical company pioneering a new era of cellular medicines. Our proprietary RED PLATFORM™ was designed to genetically engineer and culture Red Cell Therapeutics™ that are selective, potent and ready to-use cellular therapies for the potential treatment of several diseases across multiple therapeutic areas. Our initial focus is to advance RCT™ product applicants for the treatment of rare diseases, cancer and autoimmune diseases by leveraging 3 distinct therapeutic modalities — cellular shielding, potent cell-cell interaction and tolerance induction. We plan to file our 1st Investigational New Drug application (IND) for RTX-134 in phenylketonuria during the 1st quarter of 2019. We are planning to file additional INDs in rare diseases, cancer and autoimmune diseases in 2019, 2020 and beyond. The company, a 2017 “Fierce 15” award winner, was founded in 2013, is based in Cambridge, MA and is currently expanding across the all functions within the organization.